Pro Share Advisors LLC Tricida, Inc. Transaction History

Pro Share Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$4.19 - $9.56 $45,134 - $102,980	-10,772 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.56 - $4.64 $38,348 - $49,982	10,772 New	10,772 $50,000
Q2 2021 Aug 13, 2021	SELL	$3.95 - $5.41 $57,298 - $78,477	-14,506 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.52 - $7.8 $2,250 - $3,884	498 Added 3.56%	14,506 $77,000
Q4 2020 Feb 09, 2021	BUY	$4.37 - $9.46 $10,807 - $23,394	2,473 Added 21.44%	14,008 $99,000
Q3 2020 Nov 13, 2020	SELL	$8.56 - $26.93 $2,473 - $7,782	-289 Reduced 2.44%	11,535 $105,000
Q2 2020 Aug 03, 2020	BUY	$21.21 - $31.55 $250,787 - $373,047	11,824 New	11,824 $325,000
Q1 2020 May 15, 2020	SELL	$18.43 - $38.04 $252,251 - $520,653	-13,687 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$29.6 - $43.71 $64,202 - $94,806	-2,169 Reduced 13.68%	13,687 $517,000
Q3 2019 Nov 12, 2019	SELL	$29.87 - $42.22 $11,649 - $16,465	-390 Reduced 2.4%	15,856 $489,000
Q2 2019 Aug 13, 2019	SELL	$31.16 - $39.46 $93 - $118	-3 Reduced 0.02%	16,246 $641,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $14,910 - $28,849	747 Added 4.82%	16,249 $628,000
Q4 2018 Feb 14, 2019	BUY	$23.57 - $32.33 $365,382 - $501,179	15,502 New	15,502 $366,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.